Purchase Order AG91H2P170067
- Not listed
- The U.S. federal government awarded a $10,444.83 firm fixed-price purchase order to Qiagen, LLC for the QIAGEN QuantiTect Probe RT-PCR Kit (product #204445). The contract was awarded without a set-aside designation on April 22, 2015, with an ultimate completion date of May 5, 2015. The place of performance is Valencia, California. Qiagen, LLC, a foreign-owned manufacturer headquartered in Germantown, Maryland, is a subsidiary of Qiagen N.V., a multinational biotechnology company based in the...
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., was awarded a firm fixed-price purchase order on July 14, 2017, for 1,000 QuantiTect Probe polymerase chain reaction (PCR) kits with shipping. The contract, valued at $5,358.36, reflects intramall pricing and carries no set-aside designation, indicating open competition. The award was funded by a civilian federal agency with the Southeast Area designation, and the place of performance is Valencia, California. The contract is scheduled...
- The Department of the Interior U.S. Geological Survey Office of Acquisitions and Grants awarded a Firm Fixed Price Purchase Order to Qiagen, LLC, a division of the international provider Qiagen N.V., for the delivery of RT-PCR kits. The contract has a potential value of $57,508.96 and a completion date of September 20, 2015. Qiagen is an experienced federal contractor, providing a range of products and services to support agencies' biomedical research, public health, law enforcement, and...
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., received a purchase order award from the Plains Area civilian federal agency for RT2 kits valued at $5,263.30. The contract, awarded on January 25, 2018, with an ultimate completion date of January 31, 2018, utilized firm fixed-price pricing with no set-aside designation. Performance of this work will be executed in Valencia, California. As a leading provider of molecular diagnostics and scientific equipment, Qiagen regularly supplies...
- Qiagen, LLC was awarded a firm fixed-price purchase order valued at $12,719.47 on June 23, 2016, for 1,000 units of QIAGEN TYPE-LT Microsatellite PCR Kit. The contract was funded by a civilian federal agency and performed at Qiagen's location in Valencia, California. No set-aside designation was applied to this award, reflecting Qiagen's competitive standing in the open federal marketplace. As a molecular diagnostics manufacturer, Qiagen supplies specialized scientific equipment and reagents...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Qiagen, LLC for the purchase of 2,000 QuantiFAST Probe RT-PCR+ROX Vial Kits. The contract has a ceiling value of $6,426.78 and a completion date of July 31, 2015. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen...
- Qiagen, LLC, a foreign-owned molecular diagnostics and scientific equipment manufacturer headquartered in Germantown, Maryland, received a $9,527.73 firm fixed-price purchase order from a civilian federal agency for 400 reaction units of QuantiTect RT PCR Kit. The award, issued on February 6, 2019, with an ultimate completion date of February 14, 2019, represents a modification to add funds matching the vendor's order total. The contract was awarded without a set-aside designation, reflecting...
- Qiagen, LLC was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call for in vitro diagnostic substances, reagents, test kits, and sets valued at $13,132.80, with an ultimate completion date of August 17, 2015. This contract was issued by the Office of the Director at a civilian federal agency without a set-aside designation, reflecting Qiagen's ability to compete in the open federal marketplace. The place of performance is identified as Valencia, California. This award represents a...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and scientific reagents. The contract is for the supply of QIACUITY ONE-STEP VIRAL RT-PCR KITS, with a ceiling value of $129,054.54 and a completion date of September 30, 2022. The contract has no set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology...
- The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
On September 30, 2017, the Pacific West Area (a civilian federal agency) awarded a $3,798.97 firm fixed-price purchase order to Qiagen, LLC for QIAGEN ONESTEP RT-PCR Kit #210212 and QIAAMP Viral RNA Mini Kit #52906, with an ultimate completion date of October 31, 2017. The contract was awarded without set-aside designation, allowing Qiagen to compete in the open federal marketplace. The place of performance was Valencia, California. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-based multinational biotechnology company specializing in molecular diagnostics, sample preparation technologies, and bioinformatics solutions. The procured kits support molecular diagnostic capabilities, with the RT-PCR (reverse transcription polymerase chain reaction) and viral RNA extraction products serving critical applications in infectious disease detection and research. Qiagen has established itself as a significant supplier to multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense, providing specialized reagents, instrumentation, and diagnostic testing solutions. The company maintains several indefinite delivery vehicles across federal agencies, including a $2.5 million contract with the FBI and a $10 million blanket purchase agreement with the National Institute of Environmental Health Sciences, demonstrating its role as a trusted provider of molecular biology products and services to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/30/17 |